GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,634,000 | +210.1% | 37,535 | +210.3% | 0.04% | +270.0% |
| Q1 2022 | $527,000 | -14.0% | 12,096 | -13.0% | 0.01% | -16.7% |
| Q4 2021 | $613,000 | -10.8% | 13,896 | -22.7% | 0.01% | -14.3% |
| Q3 2021 | $687,000 | -6.9% | 17,988 | -2.9% | 0.01% | -6.7% |
| Q2 2021 | $738,000 | +11.6% | 18,527 | -0.0% | 0.02% | +7.1% |
| Q1 2021 | $661,000 | -34.4% | 18,532 | -32.3% | 0.01% | -39.1% |
| Q4 2020 | $1,008,000 | -20.3% | 27,387 | -18.5% | 0.02% | -28.1% |
| Q3 2020 | $1,265,000 | +24.5% | 33,606 | +34.9% | 0.03% | +18.5% |
| Q2 2020 | $1,016,000 | +16.1% | 24,919 | +8.0% | 0.03% | -10.0% |
| Q1 2020 | $875,000 | -35.3% | 23,081 | -19.8% | 0.03% | -18.9% |
| Q4 2019 | $1,352,000 | +4.5% | 28,767 | -5.1% | 0.04% | -2.6% |
| Q3 2019 | $1,294,000 | +8.3% | 30,311 | +1.5% | 0.04% | +2.7% |
| Q2 2019 | $1,195,000 | -2.5% | 29,866 | +1.9% | 0.04% | -2.6% |
| Q1 2019 | $1,226,000 | +22.2% | 29,317 | +11.7% | 0.04% | +2.7% |
| Q4 2018 | $1,003,000 | +11.6% | 26,246 | +17.3% | 0.04% | +32.1% |
| Q3 2018 | $899,000 | +11.0% | 22,381 | +11.4% | 0.03% | +12.0% |
| Q2 2018 | $810,000 | +5.6% | 20,097 | +2.4% | 0.02% | +8.7% |
| Q1 2018 | $767,000 | +168.2% | 19,634 | +143.7% | 0.02% | +155.6% |
| Q4 2017 | $286,000 | +28.3% | 8,056 | +38.9% | 0.01% | +12.5% |
| Q4 2016 | $223,000 | -13.6% | 5,801 | -2.7% | 0.01% | -11.1% |
| Q3 2016 | $258,000 | +8.4% | 5,961 | +8.6% | 0.01% | 0.0% |
| Q2 2016 | $238,000 | -15.9% | 5,489 | -21.5% | 0.01% | -18.2% |
| Q1 2016 | $283,000 | -3.7% | 6,995 | -3.9% | 0.01% | 0.0% |
| Q4 2015 | $294,000 | -11.7% | 7,277 | -16.0% | 0.01% | -15.4% |
| Q3 2015 | $333,000 | -6.7% | 8,663 | +1.1% | 0.01% | 0.0% |
| Q2 2015 | $357,000 | -8.7% | 8,568 | +1.1% | 0.01% | -13.3% |
| Q1 2015 | $391,000 | +7.1% | 8,473 | -0.7% | 0.02% | +7.1% |
| Q4 2014 | $365,000 | +29.4% | 8,533 | +38.9% | 0.01% | +27.3% |
| Q3 2014 | $282,000 | +26.5% | 6,143 | +47.3% | 0.01% | +22.2% |
| Q2 2014 | $223,000 | 0.0% | 4,170 | 0.0% | 0.01% | -10.0% |
| Q1 2014 | $223,000 | – | 4,170 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |